Key details
Sponsor
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Enrollment target
~376 participants
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated December 2025